Cargando…
The Dynamic Use of EGFR Mutation Analysis in Cell-Free DNA as a Follow-Up Biomarker during Different Treatment Lines in Non-Small-Cell Lung Cancer Patients
Epidermal growth factor receptor (EGFR) mutational testing in advanced non-small-cell lung cancer (NSCLC) is usually performed in tumor tissue, although cfDNA (cell-free DNA) could be an alternative. We evaluated EGFR mutations in cfDNA as a complementary tool in patients, who had already known EGFR...
Autores principales: | Macías, Mónica, Alegre, Estibaliz, Alkorta-Aranburu, Gorka, Patiño-García, Ana, Mateos, Beatriz, Andueza, Maria P., Gúrpide, Alfonso, Lopez-Picazo, Jose M., Gil-Bazo, Ignacio, Perez-Gracia, Jose L., González, Álvaro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6364099/ https://www.ncbi.nlm.nih.gov/pubmed/30809319 http://dx.doi.org/10.1155/2019/7954921 |
Ejemplares similares
-
Familial primary cutaneous amyloidosis: Caspase activation may be involved in amyloid formation
por: Antoñanzas, Javier, et al.
Publicado: (2022) -
Rare form of autosomal dominant familial Cornelia de Lange syndrome due to a novel duplication in SMC3
por: Infante, Elena, et al.
Publicado: (2017) -
Genomic characterization of individuals presenting extreme phenotypes of high and low risk to develop tobacco‐induced lung cancer
por: Fusco, Juan Pablo, et al.
Publicado: (2018) -
Machine Learning-Based Approach Highlights the Use of a Genomic Variant Profile for Precision Medicine in Ovarian Failure
por: Henarejos-Castillo, Ismael, et al.
Publicado: (2021) -
Insights into venous thromboembolism prevention in hospitalized cancer patients: Lessons from a prospective study
por: Figueroa, Rocío, et al.
Publicado: (2018)